MFS
EW icon

Mattson Financial Services’s Edwards Lifesciences EW Stock Holding History

Mattson Financial Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22
Closed -$1.45K – 357
2024
Q4 		$1.45K Hold
22
– – ﹤0.01% 318
2024
Q3 		$2.03K Hold
22
– – ﹤0.01% 241
2024
Q2 		$2.03K Buy
+22
New +$1.95K ﹤0.01% 241

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Mattson Financial Services's EW Position: Q1 2025 in Review

Mattson Financial Services sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 22 shares — an estimated $1.45K sold.

Mattson Financial Services first reported a position in EW in Q2 2024 and held it in 3 quarters. The position peaked at $2.03K in Q3 2024. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Mattson Financial Services reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Mattson Financial Services sold 22 Edwards Lifesciences shares in Q1 2025, an estimated $1.45K.
  • Mattson Financial Services first reported a position in Edwards Lifesciences in Q2 2024 and held it in 3 quarters.
  • Mattson Financial Services's Edwards Lifesciences position peaked at $2.03K in Q3 2024.
  • 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Mattson Financial Services's 13F filing for Q1 2025, filed 22 May 2025.